Literature DB >> 16810953

THE IDENTIFICATION OF A FLUORESCENT REDUCING SUBSTANCE IN THE URINE OF PATIENTS WITH RHEUMATOID ARTHRITIS: THE EXCRETION OF 3-HYDROXYANTHRANILIC ACID IN THIS AND OTHER CONDITIONS.

M McMillan1.   

Abstract

The report that 2,5-dihydroxyphenylpyruvic acid occurs in the urine of patients with collagen disease has not been confirmed, and no evidence was found for regarding collagen disease as being due to an inherent error in tyrosine metabolism as suggested by Japanese workers.A strongly reducing substance was conspicuous in the urine of patients with rheumatoid arthritis but not in that of normal persons. This substance was identified as 3-hydroxyanthranilic acid (3-HAA).A method is described for the measurement of 3-HAA in urine, employing ether extraction, paper chromatography in a formate solvent, and visual assessment by fluorescence in ultra-violet light and colour with Ehrlich's reagent. Normal persons excreted from less than 125 to 375 mug./day (average rather lower than 200 mug./day); those suffering from rheumatoid arthritis excreted from less than 125 to 2,250 mug./day (average 820 mug./day). The excessive excretion of 3-HAA in persons with rheumatoid arthritis was investigated in terms of other aspects of the activity of the disease. Some relationship was suggested between excretion levels, the erythrocyte sedimentation rate, and the sensitized sheep cell test. Cases of osteoarthritis, other orthopaedic conditions, and miscellaneous diseases were examined. A few of the latter, including diseases of the haemopoietic system, were associated with increased excretion of 3-HAA.

Entities:  

Year:  1960        PMID: 16810953      PMCID: PMC480022          DOI: 10.1136/jcp.13.2.140

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  Isolation of Kynurenine and 3-hydroxykynurenine from human pathological urine.

Authors:  L MUSAJO; C A BENASSI; A PARPAJOLA
Journal:  Nature       Date:  1955-05-14       Impact factor: 49.962

2.  The determination in urine of some metabolites of tryptophankynurenine, anthranilic acid and 3-hydroxyanthranilic acid- and reference to the presence of o-aminophenol in urine.

Authors:  S L TOMPSETT
Journal:  Clin Chim Acta       Date:  1959-05       Impact factor: 3.786

3.  Investigations of possible endogenous carcinogens.

Authors:  J G WATSON
Journal:  Surg Forum       Date:  1957

4.  Course and prognosis in rheumatoid arthritis.

Authors:  J J DUTHIE; P E BROWN; J D KNOX; M THOMPSON
Journal:  Ann Rheum Dis       Date:  1957-12       Impact factor: 19.103

5.  Intermediary metabolism of phenylalanine and tyrosine in diffuse collagen diseases. I. The presence of 2,5-dihydroxyphenylpyruvic acid in the urine of patients with collagen disease.

Authors:  N NISHIMURA; M YASUI; H OKAMOTO; M KANAZAWA; Y KOTAKE; Y SHIBATA
Journal:  AMA Arch Derm       Date:  1958-03

6.  The metabolism of tryptophan. 2. The metabolism of tryptophan in patients suffering from cancer of the bladder.

Authors:  E BOYLAND; D C WILLIAMS
Journal:  Biochem J       Date:  1956-11       Impact factor: 3.857

7.  The excretion of kynurenine and 3-hydroxykynurenine by man.

Authors:  C E DALGLIESH; S TEKMAN
Journal:  Biochem J       Date:  1954-03       Impact factor: 3.857

8.  The experimental aspects of industrial bladder cancer.

Authors:  G M BONSER; D B CLAYSON; J W JULL; L N PYRAH
Journal:  Br J Urol       Date:  1954-03

9.  A disturbance of tryptophan metabolism in congenital hypoplastic anaemia.

Authors:  K I ALTMAN; G MILLER
Journal:  Nature       Date:  1953-11-07       Impact factor: 49.962

10.  Observations on the oxidation of homogentisic acid in urine.

Authors:  R CONSDEN; H A W FORBES; L E GLYNN; W M STANIER
Journal:  Biochem J       Date:  1951-12       Impact factor: 3.857

  10 in total
  7 in total

1.  Metabolism of tryptophan in rheumatoid arthritis.

Authors:  I M BETT
Journal:  Ann Rheum Dis       Date:  1962-03       Impact factor: 19.103

2.  Serum pyridoxal in patients with rheumatoid arthritis.

Authors:  C R Sanderson; R E Davis; C E Bayliss
Journal:  Ann Rheum Dis       Date:  1976-04       Impact factor: 19.103

Review 3.  Aspects of tryptophan metabolism in health and disease: a review.

Authors:  D P Rose
Journal:  J Clin Pathol       Date:  1972-01       Impact factor: 3.411

4.  Tryptophan metabolism in rheumatoid neuropathies.

Authors:  F E Bruckner; H G Smith; C Lakatos; M A Chamberlain
Journal:  Ann Rheum Dis       Date:  1972-07       Impact factor: 19.103

5.  Serum kynurenine in rheumatoid arthritis.

Authors:  H Spiera; R Vallarino
Journal:  J Clin Invest       Date:  1969-05       Impact factor: 14.808

6.  Oral contraceptives and tryptophan metabolism: effects of oestrogen in low dose combined with a progestagen and of a low-dose progestagen (megestrol acetate) given alone.

Authors:  D P Rose; P W Adams
Journal:  J Clin Pathol       Date:  1972-03       Impact factor: 3.411

Review 7.  Kynurenine Pathway Metabolites as Biomarkers for Amyotrophic Lateral Sclerosis.

Authors:  Vanessa X Tan; Gilles J Guillemin
Journal:  Front Neurosci       Date:  2019-09-20       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.